AbbVie

amyloid plaque alzheimers brain

Research

Denali Alzheimer's antibody clears plaques without ARIA in mice

The Bay Area biotech plans to bring an optimized form of the antibody, which targets beta amyloid, into the clinic in 2026.

Darren Incorvaia Aug 7, 2025 2:00pm

acquisition merger arrows

AbbVie ends development of IL-1 asset in ulcerative colitis

Jul 31, 2025 12:32pm

Fierce Pharma

AbbVie will continue to pursue external innovation for long-term

Jul 31, 2025 11:44am

Question

AbbVie in talks over $1B Gilgamesh buyout: report

Jul 31, 2025 7:48am

Three blocks displaying from left to right a person a handshake and another person

AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer

Jul 10, 2025 9:01am

Graphic of two hands shaking under a red and purple light

AbbVie inks $2.1B Capstan buyout to enter in vivo CAR-T market

Jun 30, 2025 9:45am